Cancer Microbiome Sequencing Market to be dominated by Rising Incidences of Cancer through 2027
Growing focus on the
microbiome’s potential in the field of cancers to drive the cancer microbiome
sequencing market in the forecast period, 2023-2027.
According to TechSci Research
report, “Cancer Microbiome Sequencing Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2017-2027”, the global cancer
microbiome sequencing market is anticipated to grow at a significant rate in
the forecast period, 2023-2027. The decreasing cost of sequencing, growing
occurrences of cancer, and rising investments in microbiome research are the
primary factors driving the demand for the global cancer microbiome sequencing market.
The rising number of patients with cancer, rise in R&D activities, upsurge
in development of novel diagnostic tools based on microbiome for supporting
physicians, increasing healthcare expenditure, and growing awareness of the
use of microbiome sequencing technology are expected to influence the market
demand. Also, the rising adoption of inorganic growth strategies and growth
world population also a key factor for increasing the growth of the cancer
microbiome sequencing market, globally.
However, the lack of high complexity
testing centers in markets, regulatory challenges for direct-to-consumer (DTC)
companies, and existing diagnostic confidence on conventional cancer diagnostics
may hamper the growth of the global cancer microbiome sequencing market.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "Global Cancer Microbiome Sequencing Market"
The global cancer
microbiome sequencing market is segmented into component, technology,
application, end user, and company.
Based on
component, the market is divided into kits & assays, software, and
services. The kits & assays segment is anticipated to grow during the
forecast period. This is attributed to the increasing number of cases of
cancers and the launch of new and advanced assay and kits.
Based on
technology, the market is divided into next generation sequencing and
polymerase chain reaction. The next generation sequencing segment is
anticipated to grow during the forecast period. This is attributed to the rise
in adoption of next-generation sequencing in clinical oncology to advance
tailored cancer treatment.
Based on
application, the market is divided into translational research and clinical
diagnostics. The
translational research segment is anticipated to grow
during the forecast period. This is attributed to the growing R&D
activities and heavy investments in research field.
Based on end
user, the market is divided into biotechnology & pharmaceutical companies,
academic & research institutions, hospitals & clinics, and others. The hospitals
& clinics segment is anticipated to grow during the forecast period. This
is attributed to the majority of the sequencing test takes place in
laboratories for detecting various diseases.
Major
companies operating in global cancer microbiome sequencing market are:
- Illumina, Inc.
- Eurofins Scientific SE
- QIAGEN NV
- Thermo Fischer Scientific, Inc.
- Oxford Nanopore Technologies plc.
- OraSure Technologies, Inc.
- Pacific Biosciences of California, Inc.
- Psomagen, Inc
- Prescient Medicine Holdings, Inc.
- Micronoma Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“North America region
dominates the market in 2021 and is expected to maintain its dominance in the
coming years due to the rise in the adoption of highly advanced techniques and
systems. The upsurge in research and development activities, the
presence of market leaders, substantial adoption of high-fidelity cancer
microbiome sequencing products and services for translational research, rising
fund infusions by the federal organizations, and growing cases of cancer in the
region are expected to propel the global cancer microbiome sequencing market
growth till 2027” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
“Cancer Microbiome
Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2017-2027, Segmented By Component (Kits & Assays, Software,
Services), By Technology (Next Generation Sequencing v/s Polymerase Chain
Reaction), By Application (Translational Research v/s Clinical Diagnostics), By
End User (Biotechnology & Pharmaceutical Companies, Academic & Research
Institutions, Hospitals & Clinics, Others), By company and By Region”, has evaluated the future
growth potential of global cancer microbiome sequencing market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global cancer microbiome sequencing market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com